Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-15

Clinical Trial Update: Phase 1 Study of VELGRAFT, a Living Cellular Construct, in the Management of Chronic Diabetic Foot Ulcers Which Have Attained Granulation Tissue [Phase 1]

View source ↗

Summary

Clinical trial update on the Phase 1 study of VELGRAFT, a living cellular construct, for chronic diabetic foot ulcers with granulation tissue; the study is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VELGRAFT

Snippet

Sponsor: Ayu, Inc. | Conditions: Diabetic Foot Ulcer (DFU), Granulation of Chronic Diabetic Wounds | Phase 1 | Status: RECRUITING